` Comparison: MED vs ULVR - Alpha Spread

MED
vs
ULVR

Over the past 12 months, MED has underperformed ULVR, delivering a return of -28% compared to the ULVR's 0% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
MED
ULVR
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

MED Intrinsic Value
HIDDEN
Show
ULVR Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Medifast Inc
NYSE:MED
10.77 USD
Unilever PLC
LSE:ULVR
4 898.5 GBX
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
MED, ULVR

MED
ULVR
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Medifast Inc
Revenue
Unilever PLC
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
MED, ULVR

MED
ULVR
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Medifast Inc
NYSE:MED
Unilever PLC
LSE:ULVR
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

MED
71.3%
ULVR
0%
LTM 3Y Avg 5Y Avg 10Y Avg
Medifast Inc
Unilever PLC

Operating Margin

MED
-3.7%
ULVR
20%
LTM 3Y Avg 5Y Avg 10Y Avg
Medifast Inc
Unilever PLC

Net Margin

MED
-4.8%
ULVR
18.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Medifast Inc
Unilever PLC

FCF Margin

MED
0.3%
ULVR
18%
LTM 3Y Avg 5Y Avg 10Y Avg
Medifast Inc
Unilever PLC

ROE

MED
-9.1%
ULVR
53.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Medifast Inc
Unilever PLC

ROA

MED
-7%
ULVR
12.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Medifast Inc
Unilever PLC

ROIC

MED
-87.4%
ULVR
11.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Medifast Inc
Unilever PLC

ROCE

MED
-6.7%
ULVR
19.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Medifast Inc
Unilever PLC

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
MED, ULVR

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
MED, ULVR

Performance Gap Between MED and ULVR
HIDDEN
Show

Performance By Year
MED, ULVR

Loading
MED
ULVR
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare MED to other stocks
OR
L'Oreal SA
More expensive
vs MED
HINDUNILVR
Hindustan Unilever Ltd
More expensive
vs MED
HLN
HALEON PLC
More expensive
vs MED
EL
Estee Lauder Companies Inc
More expensive
vs MED
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett